Impact of Different Treatment Regimens and Timeframes in the Plasmatic Metabolic Profiling of Patients with Lung Adenocarcinoma

Impact of Different Treatment Regimens and Timeframes in the Plasmatic Metabolic Profiling of Patients with Lung Adenocarcinoma

In recent years, the treatment of advanced non-small cell lung cancer (NSCLC) has suffered a variety of alterations. Chemotherapy (CTX), immunotherapy (IT) and tyrosine kinase inhibitors (TKI) have shown remarkable results. However, not all patients with NSCLC respond to these drug treatments or rec...

Full description

Bibliographic Details
Main Authors: Daniela Madama, David F. Carrageta, Bárbara Guerra-Carvalho, Maria F. Botelho, Pedro F. Oliveira, Carlos R. Cordeiro, Marco G. Alves, Ana M. Abrantes
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Metabolites
Subjects:
lung adenocarcinoma
chemotherapy
immunotherapy
metabolomics
Online Access:https://www.mdpi.com/2218-1989/13/12/1180

Similar Items

Similar Items